Product Program year 2025 Source: CMS Open Payments

Beqvez

Biological Hematology

NDC 0069-2004-04

Open in the dashboard

General payments

$38,818

320 payments

Research payments

$626,801

125 payments

Through program year 2025, $38,818 in general payments and $626,801 in research payments were reported against Beqvez (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $5,927 70
2025 Research $272,946 74
2024 General $32,891 250
2024 Research $353,855 51

Breakdown

Who paid General payments · program years 2024–2025
  1. Pfizer Inc. $37,742 255 payments
  2. PBG Puerto Rico LLC $1,075 65 payments
Top recipients General payments · program year 2025
  1. Carol Kasper Hematology · Los Angeles, CA $1,875 32% · 1 payment
  2. Miguel Escobar Hematology · Houston, TX $1,625 27% · 2 payments
  3. Maya Bloomberg Nurse Practitioner · Miami, FL $540 9% · 1 payment
  4. Kim Schafer Nurse Practitioner, Family · Sacramento, CA $375 6% · 1 payment
  5. Constance Blunt Medical Oncology · Baton Rouge, LA $33 <1% · 1 payment

The top 5 of 69 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Hematology Internal Medicine $3,541 60% · 4 practitioners
  2. Nurse Practitioner $627 11% · 4 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $607 10% · 13 practitioners
  4. Pediatric Hematology-Oncology Pediatrics $480 8% · 19 practitioners
  5. Hematology & Oncology Internal Medicine $256 4% · 13 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $2,466 42% · 12 recipients
  2. Texas $1,640 28% · 2 recipients
  3. Florida $604 10% · 4 recipients
  4. Louisiana $437 7% · 14 recipients
  5. Mississippi $397 7% · 12 recipients

The top 5 of 12 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

320 general · 125 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record